Levetiracetam versus phenytoin for the treatment of established status epilepticus: A systematic review and meta-analysis of randomized controlled trials
- 1 May 2020
- journal article
- review article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 78, 43-48
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Chengdu Science and Technology Bureau
- National Key Research and Development Program of China Stem Cell and Translational Research
This publication has 28 references indexed in Scilit:
- Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam – Pilot studyEpilepsy Research, 2015
- Levetiracetam versus phenytoin in management of status epilepticusJournal of Clinical Neuroscience, 2015
- The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: A meta-analysis of published studiesSeizure: European Journal of Epilepsy, 2014
- Rapid Infusion of a Loading Dose of Intravenous Levetiracetam With Minimal Dilution: A Safety StudyJournal of Child Neurology, 2009
- Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analysesJournal of Clinical Epidemiology, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based studyThe Lancet, 2006
- Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentationJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Treatment delay and the risk of prolonged status epilepticusNeurology, 2005
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002